Cartesian Therapeutics (formerly Selecta Biosciences) is a clinical-stage biopharmaceutical company advancing a differentiated product pipeline to modulate the immune system. It operates through one segment: research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases.